Managing Risk With A Platform

Once your quality team has defined your priority risks, a platform designation can help whip them into submission. Building a platform alongside novel drug development gives you a template rooted in prior knowledge to control risks for subsequent products.

Our guests for Cell & Gene Live "Viability On The Line" explain how FDA's recent platform guidance, and the increasing attention to prior knowledge, pave the way for more stable raw material supply chains.